Li Jing, Chen Xiulan, Yi Jiao, Liu Yuchen, Li Dameng, Wang Jifeng, Hou Dongxia, Jiang Xiaohong, Zhang Junfeng, Wang Jin, Zen Ke, Yang Fuquan, Zhang Chen-Yu, Zhang Yujing
State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute for Life Sciences, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
Key Laboratory of Protein and Peptide Pharmaceuticals & Laboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
PLoS One. 2016 Sep 20;11(9):e0163043. doi: 10.1371/journal.pone.0163043. eCollection 2016.
Cell-derived exosomes are leading candidates for in vivo drug delivery carriers. In particular, exosomes derived from 293T cells are used most frequently, although exosome dosing has varied greatly among studies. Considering their biological origin, it is crucial to characterize the molecular composition of exosomes if large doses are to be administered in clinical settings. In this study, we present the first comprehensive analysis of the protein, messenger RNA and microRNA profiles of 293T cell-derived exosomes; then, we characterized these data using Gene Ontology annotation and Kyoto Encyclopedia for Genes and Genomes pathway analysis. Our study will provide the basis for the selection of 293T cell-derived exosome drug delivery systems. Profiling the exosomal signatures of 293T cells will lead to a better understanding of 293T exosome biology and will aid in the identification of any harmful factors in exosomes that could cause adverse clinical effects.
细胞衍生的外泌体是体内药物递送载体的主要候选者。特别是,源自293T细胞的外泌体使用最为频繁,尽管不同研究中外泌体的给药剂量差异很大。考虑到它们的生物学来源,如果要在临床环境中给予大剂量外泌体,那么表征外泌体的分子组成至关重要。在本研究中,我们首次对源自293T细胞的外泌体的蛋白质、信使RNA和微小RNA谱进行了全面分析;然后,我们使用基因本体注释和京都基因与基因组百科全书通路分析对这些数据进行了表征。我们的研究将为选择源自293T细胞的外泌体药物递送系统提供依据。分析293T细胞的外泌体特征将有助于更好地理解293T外泌体生物学,并有助于识别外泌体中任何可能导致不良临床效应的有害因素。